HARRIS LEITSTEIN: Open Payments
NPI 1376772756 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 12 payments from 5 companies in 2025. Trend: 2023 $210 · 2024 $91 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $134 |
| Lilly USA, LLC | 2 | $56 |
| Inspire Medical Systems, Inc. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ABBVIE INC. | 1 | $33 |
Products named: Rybelsus, Ozempic, INSPIRE, SYNTHROID, JARDIANCE, MOUNJARO, FASENRA.
Industry payments across NY — which companies pay providers there.
